As of July 1, 2026, the HDFC Pharma and Healthcare Fund and WhiteOak Capital Pharma and Healthcare Fund have emerged as the top-performing mutual funds in the pharma and healthcare sector based on 2-year returns.
| Scheme Name | AUM (in ₹ Crore) | Expense Ratio (%) | Invested Amount (in ₹) | Current Value (in ₹) | Annualised Return (%) |
| HDFC Pharma and Healthcare Fund | 2,359.51 | 1.97 | 5,00,000 | 7,69,079.6 | 24.02 |
| WhiteOak Capital Pharma and Heathcare Fund | 663.03 | 2.42 | 5,00,000 | 7,47,157.8 | 22.24 |
Note: The AUM and Expense Ratio is as of May 31, 2026, and the current value of investment is as of July 1, 2026.
Launched on October 4, 2023, the HDFC Pharma and Healthcare Fund has an AUM of ₹2,359.51 crore. A lump sum investment of ₹5,00,000 in this sectoral fund would have grown to ₹7,69,079.64 in 2 years, delivering an annualised return of 24.02%. The fund has an expense ratio of 1.97%. As of July 1, 2026, the fund’s NAV is ₹20.36. HDFC Pharma and Healthcare Mutual Fund benchmark its scheme against the BSE Healthcare TRI to evaluate its relative market performance.
The WhiteOak Capital Pharma and Healthcare Fund, launched on February 6, 2024, holds an AUM of ₹663.03 crore. A lump sum investment of ₹5,00,000 in this sectoral fund would have grown to ₹7,47,157.76 in 2 years, delivering an annualised return of 22.24%. The fund has an expense ratio of 2.42%. As of July 1,2026, the fund’s NAV is ₹15.9. WhiteOak Capital Mutual Fund benchmarks its pharma and healthcare scheme against the BSE Healthcare TRI to evaluate its relative market performance.
Read More: SEBI Issues Consultation Paper on AIF Investor Consent and Conflicted Transactions!
Both HDFC Pharma and Healthcare Fund and WhiteOak Capital Pharma and Healthcare Fund delivered annualised returns of up to 24.02% over 2 years. With this performance, these 2 mutual fund schemes rank among the top-performing mutual funds in the pharma and healthcare sector.
For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Mutual Fund investments are subject to market risks, read all scheme-related documents carefully.
Published on: Jul 2, 2026, 3:46 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
